NimoGel™ Shows Promise at Preventing Delayed Complications of Sudden Brain Injury in a Preclinical Study

Contrary to popular belief, New Jersey has many hidden treasures and now Edge Therapeutics, a Newark, New Jersey based biopharmaceutical company has made tremendous headway in their quest for a cure for debilitating and potentially fatal brain injuries.

Read more »

NeoGenomics Reports Fourth Quarter and Full Year 2010 Results

FT. MYERS, Fla., Feb. 10, 2011 /PRNewswire/ — NeoGenomics, Inc. (OTC Bulletin Board: NGNM), a leading provider of cancer-focused genetic testing services, today reported its results for the fourth quarter 2010 and fiscal year ended December 31, 2010.

Read more »

Mobisante Wins FDA Approval For The World’s First smartphone-­based ultrasound imaging system

Mobisante, Inc., a privately held medical device company located in Redmond, WA, announced recently that it has received 510(k) clearance from the FDA for its smartphone-based ultrasound imaging system, MobiUS.

Read more »

Interface Biologics Appoints Art Rosenthal to Chairman of its Board of Directors

Interface Biologics Inc. (IBI), a privately held commercial stage developer of transformative biomedical-polymer products recently announced the appointment of Arthur L. Rosenthal to Chairman of its Board of Directors.

Read more »

Killing Canine Cancer:Functional Nutriments Applies Ground-Breaking Therapy To Human Patients (Video)

Cancer, a word that strikes a chord of fear in many, is a fighting word. At $47.7bn, cancer is one of the largest, fastest growing markets in the pharmaceutical industry, and while it is a match we have yet to win, researchers and scientists have on their boxing gloves and are staying in the fight.

Read more »

ADVENTRX Pharmaceuticals Provides Update on ANX-514

ADVENTRX Pharmaceuticals, Inc., a specialty pharmaceutical company focused on acquiring, developing and commercializing proprietary product candidates principally for the treatment of cancer, recently provided an update on its product candidate, ANX-514, its polysorbate 80-free formulation of docetaxel.

Read more »

Small Bone Innovations Inc. Reports Significant Revenue Growth in 2010

Small Bone Innovations, Inc., an orthopedics company focused exclusively on serving patients and their physicians with technologies and treatments for joint repair (arthroplasty) and trauma reconstruction around the small bones & joints of the thumb, fingers, hand, wrist, elbow, toes, foot and ankle, recorded strong worldwide revenue growth of 24% for 2010 compared with 2009.

Read more »

A Forecast in The Diagnostic Market (video)

Advances in molecular biology now make it possible to detect diseases sooner, allowing physicians to advise patients on optimal therapies. “Global Molecular Diagnostics Market: Opportunities & Future Forecast” reports that based on its exceptional ability to accurately detect the primary cause of disease, molecular diagnostics has emerged as the fastest growing segment of the in vitro diagnostics (IVD) industry.

Read more »

Seno Medical Uses Laser-Based Technology For Early cancer Diagnosis

Seno Medical is a company focused on cancer using its new patented opto-acoustic technology.  This new imaging modality combines the […]

Read more »

Axial Biotech Has Developed the First Scoliosis Prognostic Test

Scoliosis is a degenerative spinal cord disease that leads to painful and debilitating spinal curvature, and this condition has a […]

Read more »